Skip to content

Adherence Enhancement for Renal Transplant Patients

Adherence Enhancement for Renal Transplant Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01859273
Enrollment
18
Registered
2013-05-21
Start date
2011-09-30
Completion date
2013-08-31
Last updated
2016-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Medication Adherence, Renal Failure

Keywords

renal failure, medication adherence, hypertension

Brief summary

Despite significant advances in the care of kidney transplant recipients, long term graft survival after renal transplantation remains suboptimal. Medication nonadherence and clinical inertia are key contributors to graft loss. The purpose of the proposed RCT feasibility study is to evaluate impact of a bundled wireless real time medication reminder system and blood pressure monitoring system in combination with a cognitive behavioral adherence skills enhancement program upon medication adherence, therapeutic drug concentration, and blood pressure, in nonadherent kidney transplant recipients with hypertension. We propose to recruit 60 kidney transplant recipients in phase 1 with 20 non-adherent continuing to phase 2 for a 5-month feasibility RCT.

Interventions

BEHAVIORALmHealth

mHealth prototype system consisting of electronic medication tray, blood pressure cuff and smart phone

Sponsors

Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Persons \> 21 years of age * first time recipient of a solitary kidney transplant * prescribed at least 3 medications for immunosuppression and hypertension * previous history of non-adherence * functioning kidney transplant * ability to speak, hear and understand English * able to use medication delivery device and self administer medications * able to operate blood pressure monitor * comfortable using cell phone * no other diagnosis that might shorten lifespan * transplant physician's assent that the patient can participate

Exclusion criteria

* failure to meet all inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
medication adherence5 monthsadherence to immunosuppressive medications

Secondary

MeasureTime frameDescription
blood pressure5 monthsresting blood pressure

Other

MeasureTime frameDescription
acceptability5 monthspatients' willingness to utilize the protocol mHealth system

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026